Related Experiment Videos
Chlamydia trachomatis antigen detection by Chlamydiazyme combined with Chlamydia Blocking Reagent verification.
B Zeeberg1, I Thelin, C Schalén
1Department of Medical Microbiology, Lund University Hospital, Sweden.
International Journal of STD & AIDS
|September 1, 1992
Summary
This study evaluated a new reagent to improve Chlamydia enzyme immunoassay (EIA) accuracy. Lowering the EIA cutoff increased sensitivity, and the blocking reagent confirmed true positives, reducing false results in chlamydial infection detection.
Area of Science:
- Clinical microbiology
- Immunodiagnostics
Background:
- Enzyme immunoassays (EIA) are common for detecting chlamydial infections.
- Confirmatory reagents can enhance EIA accuracy, especially with low absorbance values.
Purpose of the Study:
- To evaluate the accuracy of the Chlamydiazyme EIA using a Chlamydia Blocking Reagent.
- To assess the impact of a lowered cutoff value on EIA sensitivity.
Main Methods:
- Evaluation of a Chlamydia Blocking Reagent with Chlamydiazyme EIA.
- Analysis of male urethral and female cervical specimens.
- Comparison with direct immunofluorescence staining assay (DFA).
Main Results:
- Lowering the EIA cutoff from the manufacturer's recommendation increased sensitivity from 0.73 to 0.83.
- The blocking reagent confirmed 65% of 1101 EIA-reactive specimens as positive for Chlamydia.
- Higher confirmation rates were observed in male urethral specimens (94.3%) compared to female cervical specimens (57%).
- DFA confirmed chlamydial elementary bodies in 85% of blocking test-positive samples and 24% of blocking test-negative samples.
Conclusions:
- The Chlamydia Blocking Reagent improves the specificity of EIA for chlamydial infection detection.
- Adjusting EIA cutoff values can enhance sensitivity but requires confirmation.
- Gram-negative bacteria can cause false-positive EIA results, which are correctly identified by the blocking reagent and DFA.